Artelo Biosciences, Inc. (ARTL) Tops Q2 EPS by 4c

Artelo Biosciences, Inc. (NASDAQ: ARTL) reported Q2 EPS of ($0.75), $0.04 better than the analyst estimate of ($0.79).

For earnings history and earnings-related data on Artelo Biosciences, Inc. (ARTL) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• MSCI upgrades Bulgaria to Frontier, flags Indonesia and Turkey risks
• NSA lost access to powerful AI model amid Anthropic dispute - NYT